Document is current
Any future updates will be listed below
-
Authors
Bodien, Yelena G. https://orcid.org/0000-0003-4858-2903
Busl, Katharina M. https://orcid.org/0000-0001-9961-0527
Chang, Cherylee W. J.
Claassen, Jan https://orcid.org/0000-0002-5893-8531
Gaspard, Nicolas
Gosseries, Olivia https://orcid.org/0000-0001-9011-7496
Helbok, Raimund https://orcid.org/0000-0001-5682-0145
Massimini, Marcello
Naccache, Lionel
Newcombe, Virginia https://orcid.org/0000-0001-6044-9035
Robba, Chiara
Rohaut, Benjamin
Suarez, Jose I.
Turgeon, Alexis F.
Vespa, Paul
Wahlster, Sarah
Taccone, Fabio Silvio
Citerio, Giuseppe https://orcid.org/0000-0002-5374-3161
-
Funding
Funding for this research was provided by:
Neuroptics
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 12 November 2025
First Online: 15 December 2025
Declarations
:
: Marcello Massimini is co-founder and shareholder of Intrinc Powers. Jan Claassen is a minority shareholder at iCE Neurosystems. Virginia Newcombe holds investigator-led grants with Abbott and Roche Pharmaceuticals. All other authors declare no conflicts of interest related to this work. Chiara Robba is a Deputy Editor for Intensive Care Medicine. She has not taken part in the review or selection process of this article.
: Ethics approval was not required, because this manuscript reports the results of an expert Roundtable discussion and does not involve human subjects or identifiable patient data.
